According to the latest research report titled ‘United States Proton Therapy Market (Actual & Potential), Patients Treated, Reimbursement, Clinical Trails, Proton Therapy Centers, Major Deals, Key Company Profiles & Demand Forecasts to 2018 ? 2025’, available with Market Study Report, United States proton therapy market is projected to expand at a y-o-y growth rate of 15% throughout 2020-2025, subsequently accumulating over USD 7 billion by the end of the forecast period.
 

The report on United States proton therapy market encompasses latest data on the actual and potential business scenario with respect to historical data from 2012 to 2017 and forecasts till 2025. It boasts of a detailed account of the proton therapy center (installed base) and number of treatment rooms established by companies operating in the nation. Moreover, the report offers vast data on the current applications, followed by comparative analysis focused on positives & negatives of proton therapy, ion therapy, and radiotherapy. Further, a complete assessment of the regulatory and reimbursement landscape is hosted in the document. 
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/1114665/
 

Taking the analysis further, United States proton therapy market report makes inclusion of a dedicated section for analysis of the various components of a proton therapy center, including proton accelerator, beam delivery system, beam transport system, nozzle, image viewers, treatment planning systems, patient positioning system (PPS), and human resources. Additionally, insights on proton therapy clinical trials with respect to phase, institute, and country is compiled in the document.   
 

Speaking of the competitive arena of United States proton therapy market, IBA, in 2017, accounted the highest number of proton therapy centers in nation, followed by Hitachi Ltd. The other major players in this business sphere are Optivus Proton Therapy, Inc., Mevion Medical Systems, Inc., and Varian Medical Systems. All these companies are assessed based on their product portfolio, number of proton therapy centers developed, and recent developments like partnerships, collaborations, licensing deals, and investment.